Diagnostic Evaluation of Pediatric Nephrotic Syndrome

Clinical Presentation and Diagnosis

The American Academy of Pediatrics recommends that a child presenting with periorbital edema, heavy proteinuria, and recent viral illness should be evaluated for nephrotic syndrome 1
The International Society of Nephrology defines nephrotic syndrome as proteinuria >40 mg/m²/hour in children, or spot urine protein-to-creatinine ratio >0.2 g/g, with heavy proteinuria (≥1.0 g/m²/day) and hypoalbuminemia and edema 2
Quantifying proteinuria via 24-hour collection or spot protein-to-creatinine ratio is essential to confirm the diagnosis and guide management, with a strength of evidence rated as high 2, 3

The Kidney Disease: Improving Global Outcomes (KDIGO) guideline recommends that serum albumin levels be obtained to complete nephrotic syndrome criteria, with hypoalbuminemia (<2.5 g/dL in children) being a consequence of proteinuria 2
The American College of Pediatric Nephrology recommends initiating corticosteroid therapy if nephrotic syndrome is confirmed, with a treatment goal of reducing proteinuria and improving serum albumin levels 2
Renal biopsy is not indicated unless steroid-resistant (persistence after 4 weeks of prednisone 60 mg/m²), with a strength of evidence rated as moderate 2

The Clinical and Laboratory Standards Institute recommends obtaining basic labs, including complete blood count, urea, creatinine, electrolytes, and cholesterol, to identify complications and monitor treatment response 4, 1
The National Institute of Diabetes and Digestive and Kidney Diseases recommends monitoring urine protein-to-creatinine ratio and serum albumin levels to assess treatment response and adjust therapy as needed 2

Quantification of proteinuria via 24-hour collection or spot protein-to-creatinine ratio is more useful for monitoring treatment response rather than initial diagnosis when dipstick shows +4, according to the American Journal of Kidney Diseases 5
Renal ultrasound is appropriate when investigating hematuria, infection, or structural abnormalities, as stated by Clinical Infectious Diseases 6